Literature DB >> 18644975

Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Jianshi Yu1, Scott Becka, Peng Zhang, Xiaodong Zhang, Susann M Brady-Kalnay, Zhenghe Wang.   

Abstract

Receptor protein tyrosine phosphatase T (PTPRT/PTPrho) is frequently mutated in human cancers including colon, lung, gastric, and skin cancers. More than half of the identified tumor-derived mutations are located in the extracellular part of PTPrho. However, the functional significance of those extracellular domain mutations remains to be defined. Here we report that the extracellular domain of PTPrho mediates homophilic cell-cell aggregation. This homophilic interaction is very specific because PTPrho does not interact with its closest homologue, PTPmu, in a cell aggregation assay. We further showed that all five tumor-derived mutations located in the NH(2)-terminal MAM and immunoglobulin domains impair, to varying extents, their ability to form cell aggregates, indicating that those mutations are loss-of-function mutations. Our results suggest that PTPrho may play an important role in cell-cell adhesion and that mutational inactivation of this phosphatase could promote tumor migration and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644975      PMCID: PMC2614372          DOI: 10.1158/1541-7786.MCR-07-2123

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  24 in total

1.  Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn).

Authors:  G C Zondag; A B Reynolds; W H Moolenaar
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu.

Authors:  Valeriu B Cismasiu; Stefan A Denes; Helmut Reiländer; Hartmut Michel; Stefan E Szedlacsek
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

Review 3.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer.

Authors:  Ugo Cavallaro; Gerhard Christofori
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

5.  Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase.

Authors:  M F Gebbink; G C Zondag; R W Wubbolts; R L Beijersbergen; I van Etten; W H Moolenaar
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

Review 6.  Receptor protein tyrosine phosphatases regulate neural development and axon guidance.

Authors:  Sonya E Ensslen-Craig; Susann M Brady-Kalnay
Journal:  Dev Biol       Date:  2004-11-01       Impact factor: 3.582

7.  Mutational analysis of the tyrosine phosphatome in colorectal cancers.

Authors:  Zhenghe Wang; Dong Shen; D Williams Parsons; Alberto Bardelli; Jason Sager; Steve Szabo; Janine Ptak; Natalie Silliman; Brock A Peters; Michiel S van der Heijden; Giovanni Parmigiani; Hai Yan; Tian-Li Wang; Greg Riggins; Steven M Powell; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

8.  Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism.

Authors:  A Radu Aricescu; Christian Siebold; Kaushik Choudhuri; Veronica T Chang; Weixian Lu; Simon J Davis; P Anton van der Merwe; E Yvonne Jones
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

9.  Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation.

Authors:  S M Brady-Kalnay; A J Flint; N K Tonks
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Genomic structure and alternative splicing of murine R2B receptor protein tyrosine phosphatases (PTPkappa, mu, rho and PCP-2).

Authors:  Julie Besco; Magdalena C Popesco; Ramana V Davuluri; Adrienne Frostholm; Andrej Rotter
Journal:  BMC Genomics       Date:  2004-02-11       Impact factor: 3.969

View more
  27 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

3.  Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.

Authors:  Scott Becka; Peng Zhang; Sonya E L Craig; David T Lodowski; Zhenghe Wang; Susann M Brady-Kalnay
Journal:  Cell Commun Adhes       Date:  2010-04

4.  MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis.

Authors:  Marco Ragusa; Alessandra Majorana; Barbara Banelli; Davide Barbagallo; Luisa Statello; Ida Casciano; Maria Rosa Guglielmino; Laura Rita Duro; Marina Scalia; Gaetano Magro; Cinzia Di Pietro; Massimo Romani; Michele Purrello
Journal:  J Mol Med (Berl)       Date:  2010-06-25       Impact factor: 4.599

5.  Matching cancer genomes to established cell lines for personalized oncology.

Authors:  Joel T Dudley; Rong Chen; Atul J Butte
Journal:  Pac Symp Biocomput       Date:  2011

Review 6.  Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

7.  Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.

Authors:  Vivian Wai Yan Lui; Noah D Peyser; Patrick Kwok-Shing Ng; Jozef Hritz; Yan Zeng; Yiling Lu; Hua Li; Lin Wang; Breean R Gilbert; Ignacio J General; Ivet Bahar; Zhenlin Ju; Zhenghe Wang; Kelsey P Pendleton; Xiao Xiao; Yu Du; John K Vries; Peter S Hammerman; Levi A Garraway; Gordon B Mills; Daniel E Johnson; Jennifer R Grandis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

8.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.

Authors:  Chun Feng Lee; Zhi Qiang Ling; Ting Zhao; Shih Hua Fang; Weng Cheng Chang; San Chih Lee; Kuan Rong Lee
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Authors:  Adam M Burgoyne; Polly J Phillips-Mason; Susan M Burden-Gulley; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; Susann M Brady-Kalnay
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.